Abstract Details
Luis A. Sierra, Jr.
(Beth Israel Deaconess Medical Center)
PRESENTER |
Mr. Sierra has nothing to disclose. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Samuel A. Frank, MD, FAAN (Beth Israel Deaconess Medical Center/Harvard Medical School) | Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBIO. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel. |
Simon Laganiere, MD (Beth Israel Deaconess Medical Ctr) | Dr. Laganiere has nothing to disclose. |